Find a Clinical Trial

Find a clinical trial underway at the OSUCCC – James.

Search by Keyword

(i.e. John Smith, 197102, Phase 3)

Showing 1-10 of 31

Filtered By: Breast

Open To Accrual

Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer

Protocol NumberOSU-19327

Open To Accrual

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/NSABP B-63)

Protocol NumberOSU-23226

Open To Accrual

A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy

Protocol NumberOSU-24110

Open To Accrual

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Protocol NumberNRG-BR009

Open To Accrual

OSU-22167: Ph3 St Gedatolisib Comb Palbociclib and Fulvest SOC Pts HR-Pos, HER2-Neg Br Ca

Protocol NumberOSU-22167

Open To Accrual

Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid Tumors

Protocol NumberOSU-20211

Open To Accrual

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Protocol NumberNRG-BR007

Open To Accrual

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Protocol NumberOSU-20331

Open To Accrual

Secondary BRain Metastases Prevention After Isolated Intracranial Progression on Trastuzumab/Pertuzumab or T-DM1 in Patients With aDvanced Human Epidermal Growth Factor Receptor 2+ brEast Cancer With the Addition of Tucatinib

Protocol NumberOSU-22278

Open To Accrual

ATEMPT 2.0: Adjuvant T-DM1 vs TH

Protocol NumberOSU-22081